Laval, Canada

Jean-Francois Lévesque

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jean-Francois Lévesque

Introduction

Jean-Francois Lévesque is a notable inventor based in Laval, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of bacterial infections. His innovative work has led to the development of a unique patent that addresses a critical health issue.

Latest Patents

Lévesque holds a patent for "Mannose derivatives for treating bacterial infections." This invention relates to compounds that are useful for the treatment or prevention of bacterial infections. The compounds described in the patent have a specific formula and include processes for their production. Additionally, the invention provides a composition that includes these compounds along with a pharmaceutically acceptable carrier, adjuvant, or vehicle. The methods outlined in the patent detail how to treat or prevent bacterial infections in subjects by administering an effective amount of the compound or composition.

Career Highlights

Jean-Francois Lévesque is associated with Vertex Pharmaceuticals, Inc., a company known for its commitment to innovative drug development. His work at Vertex has allowed him to focus on creating solutions that can significantly impact patient care and treatment outcomes.

Collaborations

Lévesque has collaborated with several professionals in his field, including Evelyne Dietrich and Carl Poisson. These collaborations have likely contributed to the advancement of his research and the successful development of his patent.

Conclusion

Jean-Francois Lévesque's contributions to the field of pharmaceuticals through his patent on mannose derivatives highlight his innovative spirit and dedication to improving health outcomes. His work exemplifies the importance of research and collaboration in the fight against bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…